Citations

Institution: Mayo Clinic Clear

Showing 10 of 108152 citations.

Increased occurrence of malignancy before and after chemoradiation for anal squamous cell carcinoma: a multi-institutional analysis
Kumar, Ritesh , Hallemeier, Chris L., Lu, Shou‐En , Hristidis, Vasilis , Jethwa, Krishan R. , Baclay, J.R.M. , Chakrani, Z., Haddock, Michael G. , Toesca, Diego A.S. , Pollom, Erqi L., Jethwa, Krishan , Baclay, J Richelcyn M , Manne, Veeraswamy , Chakrani, Zakaria , Toesca, Diego Augusto Santos, Pollom, Erqi Liu , Wu, Abraham J , Sandhyavenu, Harigopal , Romesser, Paul B , Jabbour, Salma K , Chang, Daniel T. , Hathout, Lara , Sandhyavenu, Harigopal , Romesser, Paul B.

JNCI: Journal of the National Cancer Institute | November 27, 2024 | Volume: 117 | Issue: 4 | Pages: 772-780

10.1093/jnci/djae309 | PMID 39626307 Get It

Abstract Background Anal squamous cell carcinoma is a rare cancer with increased occurrence of multiple cancers before and after the anal squamous cell carcinoma diagnosis. However, there are limited data on this aspect. This multi-institutional analysis aimed to define the occurrence of malignancies before and after anal squamous cell carcinoma, time trends, and impact on survival and to identify prognostic factors. Methods Initial primary malignancy was defined as a malignancy occurring before the anal squamous cell carcinoma. Second primary malignancy was defined as a distinct primary cancer that developed after anal squamous cell carcinoma diagnosis. Retrospective multi-institutional chart review was done. Progression-free survival (PFS), overall survival, and prognostic factors were evaluated. Results A total of 647 patients with anal squamous cell carcinoma treated with curative intent were analyzed. Median age was 61.2 years with 72% as females. Of these, 150 (23.3%) patients had multiple malignancies with initial primary malignancy in 16% and second primary malignancy in 8%. Patients without prior cancer had better 5-year PFS (81.2% vs 67.2%, P = .011) and overall survival (81% vs 69%, P = .008) compared with those with prior cancer. Second primary malignancies had a statistically significant adverse impact on PFS (hazard ratio [HR] = 4.22) and overall survival (HR = 3.56). Females had better 5-year PFS (82% vs 70%, P = .016) as compared with males. The median time interval for developing anal squamous cell carcinoma (as second primary malignancy) after initial primary malignancy was 9.32 years. Conclusions Anal squamous cell carcinoma patients have an increased risk of multiple malignancies. These patients who have prior cancers have inferior outcomes. Second primary malignancy is a poor prognostic factor in patients with anal cancer. Second primary malignancy can develop years after treatment of primary anal squamous cell carcinoma.
Applying Conformal Prediction to a Deep Learning Model for Intracranial Hemorrhage Detection to Improve Trustworthiness
Gamble, Cooper U. , Faghani, Shahriar , Erickson, Bradley J. , Gamble, Cooper , Erickson, Bradley J , Faghani, Shahriar

Radiology: Artificial Intelligence | November 27, 2024 | Volume: 7 | Issue: 2 | Pages: No page available

10.1148/ryai.240032 | PMID 39601654 Get It

An uncertainty-aware deep learning model developed using Mondrian conformal prediction demonstrated high performance in intracranial hemorrhage detection on noncontrast head CT volumes and high accuracy in identifying challenging cases.
Contrast Media in Children: Ten Important Concepts on Administration, Applications, Complications, and Environmental Considerations, From the AJR Special Series on Contrast Media
Forbes-Amrhein, Monica M., Chow, Jeanne S. , Kim, Helen H. R. , Krishnamurthy, Rajesh , McDonald, R.J. , Scheller, Leah G., Stein, Deborah R., Callahan, Michael J. , Horst, Kelly K. , Maloney, Ezekiel J. , Gilligan, Leah A.

American Journal of Roentgenology | November 27, 2024 | Volume: 225 | Issue: 4 | Pages: No page available

10.2214/ajr.24.32009 | PMID 39602099 Get It

Ancestral Differences in Anticancer Treatment Efficacy and Their Underlying Genomic and Molecular Alterations
Luo, Mei , Yang, Jingwen , Schäffer, Alejandro A. , Chen, Chengxuan , Liu, Yuan , Chen, Yamei , Lin, Chunru , Diao, Lixia , Zang, Yong , Lou, Yanyan , Salman, Huda , Mills, Gordon B , Ruppin, Eytan , Han, Leng , Salman, Huda , Mills, Gordon B. , Han, Leng

Cancer Discovery | November 27, 2024 | Volume: 15 | Issue: 3 | Pages: 511-529

10.1158/2159-8290.cd-24-0827 | PMID 39601595 Get It

Abstract Systematic multiomic analysis has revealed ancestry-dependent molecular alterations, but their impact on the efficacy of anticancer treatment is yet largely unknown. In this study, we analyzed clinical trials from ClinicalTrials.gov and found that only 8,779/102,721 (8.5%) oncology clinical trials posted information on enrollment by race/ethnicity. The underrepresentation of non-White populations suggests that it remains challenging to determine differences in the efficacy of antitumor treatments among different racial groups. Through a comprehensive analysis of clinically actionable genes, imputed drug responses, and immune features, we identified potential differences in treatment responses to targeted therapy, chemotherapy, and immunotherapy between different ancestral populations. Further analysis of multiple independent cohorts confirmed some of our key findings. Such potential ancestral effects are also identified in response to emerging new treatments like chimeric antigen receptor T-cell therapy and proteolysis-targeting chimeras. These findings are made publicly available in a comprehensive web portal, Ancestral Differences of Efficacy in Cancers (https://hanlaboratory.com/ADEC), to facilitate their further investigation. Significance: Our study charts a global landscape of ancestry-associated differences in therapeutic efficacy, highlighting the importance of considering ancestry in anticancer therapies.
Prediction of lung disease in children with laryngotracheoesophageal clefts
EA, Hosfield, HC, Patten, PE, Hopson, Cofer, Shelagh A. , JP, Wiedermann, Boesch, R. Paul , Hosfield, Emily A., Hopson, Puanani

No container title available | November 27, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.173271444.48009559/v1 Get It

Introduction: Laryngotracheoesophageal clefts (LTEC) are well-known aspiration-associated lesions. Results of swallow studies, and respiratory, feeding, and swallowing symptoms are commonly used indications for repair, despite being unclear predictors of disease. Although lung inflammation and injury are primary concerns, such findings are uncommonly and inconsistently evaluated and reported and therefore it remains unclear how well swallow studies predict lung disease. Methods: Children seen in our Aerodigestive program 10/1/2012 and 9/30/2023, with a LTEC and a videofluoroscopic swallow study (VFSS) or flexible endoscopic evaluation of swallowing (FEES) were included. Data regarding clinical history and risk factors, BAL, chest CT, and impedance probe results were abstracted, along with VFSS/FEES results and functional oral intake scale (FOIS-P/I) at baseline and follow-up. Results: 82 subjects identified. Lung inflammation and bronchiectasis were common and correlated. Clinical factors, impedance probe, and the presence/severity of swallowing abnormalities on VFSS/FEES were not predictive of lung disease. 57 patients underwent LTEC repair for a range of indications, only 49% based on CT and/or BAL findings. LTEC repair was associated with a trend towards improvement feeding and swallowing, yet none of these met statistical significance. Discussion: Children with LTEC have a high prevalence of inflammatory lung disease and injury and undergo repair for a variety of reasons. The insufficient ability of swallow study to identify patients with lung disease suggests that such studies identify functional abnormalities but not a disease state, per se. Nevertheless, LTEC repair is associated with improvements in feeding and swallowing in a subset of patients.
Sex Differences in Patient-Reported Outcomes and Perception of Ascites Burden Among Outpatients With Decompensated Cirrhosis and Ascites
Wong, Florence , Reddy, K. Rajender , Tandon, Puneeta , Lai, Jennifer C. , García‐Tsao, Guadalupe , O'leary, Jacqueline, Biggins, Scott W. , Vargas, Hugo E. , Thacker, Leroy R. , Kamath, Patrick S. , Bajaj, Jasmohan S. , Group, The NACSELD III Study, O'Leary, Jacqueline G , Thacker, Leroy R , Tandon, Puneeta , Wong, Florence , Lai, Jennifer , Vargas, Hugo E , García–Tsao, Guadalupe , Group, The NACSELD III Study

American Journal of Gastroenterology | November 27, 2024 | Volume: 120 | Issue: 8 | Pages: 1791-1799

10.14309/ajg.0000000000003251 | PMID 39601412 Get It

INTRODUCTION: Perception of the ascites burden and its effects on quality of life may be different between sexes. This study assessed sex differences in perception of ascites burden and its impact on health-related quality of life (HRQoL) in patients with recurrent or refractory ascites. METHODS: The North American Consortium for the Study of End-stage Liver Disease prospectively enrolled outpatients with cirrhosis and large ascites requiring repeat large volume paracenteses. Demographics, laboratory results, comorbidities, medications, frailty measurements, and self-reported questionnaires related to functional status, physical activities, and HRQoL (generic = Short Form 36 and ascites specific = Ascites Questionnaire) were compared between sexes. RESULTS: In total, 392 men (59.6 ± 10.7 years) and 184 women (59.5 ± 11.1 years) with predominantly alcohol-related liver disease (51% and 43%, respectively) and median Model for End-Stage Liver Disease-Na: 13 were enrolled. Both groups had similar comorbidities and cirrhosis complications, ascites duration and severity, and frailty scores ( P = 0.94). Women had more symptoms related to their ascites (Ascites Questionnaire score = 66 ± 21 vs 60 ± 21 in men, P = 0.001) (higher value = feeling worse). 35% of women felt depressed vs 22% of men ( P = 0.0009), with lower mental but not physical functioning components of Short Form 36 ( P = 0.019). Women continued to conduct their daily activities as adequately as men as indicated by Duke Status Activity Index ( P = 0.27) and Godin Leisure Activity Index ( P = 0.47). DISCUSSION: Women with cirrhosis and ascites experienced worse emotional HRQoL than men without difference in daily function. Our analyses underscore the differences in the lived experience of women vs men with cirrhosis and highlight the need for patient-reported metrics to provide patient-centered care.
Society of Radiologists in Ultrasound response to ‘Proposed simplified protocol for initial assessment of endometriosis with transvaginal ultrasound’
Young, Scott W. , VanBuren, W., Kho, Rosanne M. , Groszmann, Yvette S. , Feldman, Myra , Khan, Zaraq , Young, S. L., Endometriosis, the Society of Radiologists in Ultrasound Consensus Panel on Routine Pelvic Ultrasound for, Young, Scott W , Jha, Priyanka , Rodgers, Shuchi K. , Burnett, Tatnai L. , Chamié, Luciana Pardini , Horrow, Mindy M. , Young, S. L., Young, Steven L. , Endometriosis, the Society of Radiologists in Ultrasound Consensus Panel on Routine Pelvic Ultrasound for

Ultrasound in Obstetrics & Gynecology | November 27, 2024 | Volume: 65 | Issue: 2 | Pages: 243-245

10.1002/uog.29147 | PMID 39601344 Get It

Linked article: This Correspondence comments on Deslandes and Leonardi. Click here to view the article.
Challenges in renally eliminated medication use: Evaluating cystatin C and serum creatinine eGFR discordance
Hernandez, Brandy N., Wieruszewski, Patrick M. , Barreto, Jason N. , Cole, Kristin C., Damani, Shivam, Kane‐Gill, Sandra L. , Kelly, Ellen , Teaford, Hilary R. , Zand, Jaleh , Frazee, Erin N. , Mara, Kristin C. , Frazee, Erin N , Kane-Gill, Sandra L , Mara, Kristin C , Wieruszewski, Patrick M , Kashani, Kianoush , Kelly, Ellen, Rule, Andrew D.

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy | November 27, 2024 | Volume: 44 | Issue: 12 | Pages: 898-906

10.1002/phar.4627 | PMID 39601345 Get It

AbstractBackgroundAccurately estimating glomerular filtration rate (GFR) is crucial for dosing medications in hospitalized patients. Due to limitations of serum creatinine for GFR estimation, serum cystatin C (CysC) has been explored as an alternative functional kidney biomarker. This study assessed discordance between eGFRCr and eGFRCysC in a large sample of hospitalized patients and examined the frequency of renally eliminated medications affected by eGFR discordance.MethodsThis multisite historical study included adults hospitalized between 2011 and 2023 with CysC and serum creatinine reported within 24 h of each other. The first concurrent biomarker pair for each patient was analyzed. eGFR discordance and use of renally eliminated medications were described.Results17,718 hospitalized patients with concurrent creatinine and CysC assessments were included. The median eGFRCr was 65 mL/min, and the eGFRCysC was 46 mL/min. The median absolute difference of eGFRCr−eGFRCysC was 15 mL/min, and 7972 patients (45%) had a > 30% absolute difference. There was a significantly greater percentage of patients with an eGFR <30 mL/min based on eGFRCysC (26%) compared to eGFRCr (15%) (p < 0.001). Patients were prescribed an average of 20 medications in the 24 h surrounding the concurrent biomarker assessment. Renally eliminated medications accounted for 39% ± 13% of medication orders, and 80% of patients with eGFR discordance were prescribed five or more renally eliminated medications.ConclusionSubstantial eGFR discordance between eGFRCysC and eGFRCr was observed in hospitalized patients, which directly affects the dosing of renally eliminated medications. Further research is needed to optimize the pharmacotherapy of renally eliminated medications with discordant GFR assessments to improve medication safety and effectiveness.
Spigelian Hernia Unveiled: A Case Report of Unexpectedly Extended Hernial Sac and Successful Surgical Intervention
Mansour, Marah , Saiouf, Yaman , Deeb, Dani, Almokdad, Mohammad Yaman, Gharib, Karim

Clinical Case Reports | November 27, 2024 | Volume: 12 | Issue: 12 | Pages: No page available

10.1002/ccr3.9605 | PMID 39605852 Get It

ABSTRACTSpigelian hernia is a rare type of abdominal hernia; diagnosis is primarily through computed tomography, which is crucial for accurate diagnosis and planning early surgical intervention to preserve the herniated sac's contents.